These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12832258)

  • 1. Side effects of ziprasidone.
    Teich J
    Am J Psychiatry; 2003 Jul; 160(7):1355-6. PubMed ID: 12832258
    [No Abstract]   [Full Text] [Related]  

  • 2. Torsades de pointes associated with ziprasidone.
    Heinrich TW; Biblo LA; Schneider J
    Psychosomatics; 2006; 47(3):264-8. PubMed ID: 16684946
    [No Abstract]   [Full Text] [Related]  

  • 3. Electrocardiographic changes with ziprasidone.
    Loebel A; Miceli J; Chappell P; Siu C
    J Am Acad Child Adolesc Psychiatry; 2006 Jun; 45(6):636-637. PubMed ID: 16721311
    [No Abstract]   [Full Text] [Related]  

  • 4. Experience with ziprasidone.
    Patel NC; Sierk P; Dorson PG; Crismon L
    J Am Acad Child Adolesc Psychiatry; 2002 May; 41(5):495. PubMed ID: 12014778
    [No Abstract]   [Full Text] [Related]  

  • 5. Ziprasidone: first year experience in a hospital setting.
    Centorrino F; MacLean E; Salvatore P; Kidwell JE; Fogarty KV; Berry JM; Baldessarini RJ
    J Psychiatr Pract; 2004 Nov; 10(6):361-7. PubMed ID: 15583517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-dose ziprasidone associated with QT interval prolongation.
    Witsil JC; Zell-Kanter M; Mycyk MB
    Am J Emerg Med; 2012 Jun; 30(5):837.e1-2. PubMed ID: 21641143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug safety evaluation of ziprasidone.
    Citrome L
    Expert Opin Drug Saf; 2011 May; 10(3):437-48. PubMed ID: 21332416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QT interval--what is normal? Comment on "single-dose ziprasidone associated with QT interval prolongation".
    Sanaei-Zadeh H
    Am J Emerg Med; 2012 May; 30(4):627. PubMed ID: 22306388
    [No Abstract]   [Full Text] [Related]  

  • 9. What can large simple trials do for psychiatry?
    Stroup TS
    Am J Psychiatry; 2011 Feb; 168(2):117-9. PubMed ID: 21297045
    [No Abstract]   [Full Text] [Related]  

  • 10. Ziprasidone in the management of schizophrenia : the QT interval issue in context.
    Taylor D
    CNS Drugs; 2003; 17(6):423-30. PubMed ID: 12697001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk of QTc prolongation due to combination of ziprasidone and quetiapine].
    Minov C
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S142-4. PubMed ID: 15570533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolongation of QTc interval and antipsychotics.
    Taylor DM
    Am J Psychiatry; 2002 Jun; 159(6):1062; author reply 1064. PubMed ID: 12042205
    [No Abstract]   [Full Text] [Related]  

  • 13. Question regarding ziprasidone and QTc interval prolongation in the ZODIAC study.
    Vieweg WV; Hasnain M
    Am J Psychiatry; 2011 Jun; 168(6):650-1; author reply 651. PubMed ID: 21642483
    [No Abstract]   [Full Text] [Related]  

  • 14. Ziprasidone and the QTc interval: pharmacokinetic and pharmacodynamic considerations.
    Kelly DL; Love RC
    Psychopharmacol Bull; 2001; 35(4):66-79. PubMed ID: 12397857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of switching to ziprasidone in italian patients with acute exacerbation of schizophrenia: an open-label trial.
    Mencacci C;
    Pharmacopsychiatry; 2012 Sep; 45(6):236-40. PubMed ID: 22592506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [QTc-interval prolongation in therapy with atypical antipsychotics--results of an open, non-randomized survey].
    Finzel M; Fric M; Laux G
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S178-80. PubMed ID: 15570546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inadvertent administration of intravenous ziprasidone leading to bradycardia and QT interval prolongation.
    Bentley ML; Biscardi FH; Butcher C; Levitov A
    Ann Pharmacother; 2008 Jun; 42(6):902-3. PubMed ID: 18477728
    [No Abstract]   [Full Text] [Related]  

  • 18. Tardive dystonia associated with ziprasidone.
    Papapetropoulos S; Wheeler S; Singer C
    Am J Psychiatry; 2005 Nov; 162(11):2191. PubMed ID: 16263868
    [No Abstract]   [Full Text] [Related]  

  • 19. Ziprasidone-induced tardive dyskinesia.
    Mendhekar DN
    Can J Psychiatry; 2005 Aug; 50(9):567-8. PubMed ID: 16262114
    [No Abstract]   [Full Text] [Related]  

  • 20. Ziprasidone approved.
    Hirsch M
    Harv Ment Health Lett; 2001 Jun; 17(12):8. PubMed ID: 11439926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.